Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
Qian Sun(Rutgers, The State University of New Jersey), Hongbing Zhang(Hebei University of Economics and Business), Boshi Wang(Renji Hospital), Wenjing Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Feng Wei(National University of Singapore), Haiyong Peng(University of Florida), Liang Liu(Xuzhou Medical College), Xinxin Chen(Jilin University), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanan Wang(Luoyang Central Hospital Affiliated to Zhengzhou University), Yu Zhang(Guangzhou University of Chinese Medicine), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Rongrong Chen(Xi'an International Studies University), Hui Li(Shanghai Jiao Tong University), Xi‐Ying Zhang(Tianjin Medical University Cancer Institute and Hospital), Xiangli Jiang(Tianjin Medical University Cancer Institute and Hospital), Shuzhan Li(Tianjin Medical University Cancer Institute and Hospital), Chunjia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Zheng(Ningbo University)
Cited by 80
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
|Journal of Clinical Investigation|2003|479
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
|Journal of Clinical Investigation|2007|381